Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Calamine 15% w/v, zinc oxide 5% w/v Topical solution David Craig Pharmaceuticals, Rocklea, Brisbane, Queensland, Australia Calamine Lotion Ibuprofen 200 mg, pseudoephedrine hydrochloride 30 mg Tablet The Boots Company PLC., Nottingham, England Nurofen Cold & Flu Methylprednisolone (as methylprednisole suleptanate) 50 mg/ml in 0.4 ml, and 100 mg/ml in 1.25 ml, 2.5 ml, 5.0 ml, 10.0 ml Solution for iv injection N V Upjohn SA, Puurs, Belgium Promedrol Adenosine 6 mg in 2 ml Solution for iv injection Sanofi Winthrop Industrie, Notre Dame de Bondeville, France Adenocor Diltiazem hydrochloride 120 mg, 180 mg, 240 mg Note: Not to be marketed as substitutable for any other diltiazem hydrochloride product as if the (2) products were bioequivalent. Capsule (modified release) Armour Pharmaceutical Co., Bradley, Illinois, United States of America Dilacor XR Dated this 9th day of December 1994. D. SMITH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.